Aims and Objectives
On the 10th anniversary of the Japanese UTI Committee, its chairman (Professor Masaaki Ohkoshi) invited interested colleagues from North America and Europe to the 1st International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection, in October 1989 in Tokyo, Japan. The international commission for UTI was founded, which later became affiliated to the International Society of Antimicrobial Chemotherapy. It was decided to organize an International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection biannually, in connection with the International Congress of Chemotherapy.
International Symposia on Clinical Evaluation of Drug Efficacy in UTI
The aims of these meetings are to discuss the various aspects of UTI on a broad international base, to achieve a widely accepted consensus concerning management and clinical studies and to come to a growing bibliography on this subject, which could be useful for the daily clinical decisions to be made.
Projects / Publications
The Masaaki Ohkoshi Award
The award was founded in 1995 for the best clinical study on the subject of urinary tract infections published during a two-year period. The first three awards were sponsored by Professor Masaaki Ohkoshi and all subsequent awards have been sponsored by the Japanese UTI Committee. These awards have been presented at every International Congress of Chemotherapy since 1995 and the most recent recipient awardees were Ildikó Gagyor and Jutta Bleidorn from Germany who were presented in Taiwan, 2017.
Please click HERE for more information.
International Consultation on Urogenital Infections. Naber KG, Schaeffer AJ, Heyns C, Matsumoto T, Shoskes DA, Bjerklund Johansen TE. First edition 2010. European Association of Urology.
The international consultation on urogenital infections was a joint consultation initiated by the International Consultation on Urological Diseases (ICUD), the European Association of Urology (EAU), the Asian Association of UTI/STD, the Society of Infection and Inflammation in Urology (SIIU) and the UTI commission of the International Society of Chemotherapy for Infection and Cancer (ISC). This international consultation on urogential infections will be updated in 2016 in the form of a living textbook.
European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. P. Tenke, B. Kovacs, T.E. Bjerklund, Johansen, T. Matsumoto, P.A. Tambyah, K.G. Naber. International Journal of Antimicrobial Agents (2008) S68 – S78.
The ISAC Working Group on UTI collaborated with the following bodies to publish the guidelines detailed above:European Association of UrologyEuropean Society for Infections in UrologyUrological Association of AsiaAsian Association of UTI / STD Western Pacific Society for ChemotherapyFederation of European Societies for Chemotherapy and Infection
UTI Commission Symposia
The proceedings of the UTI Commission Symposia have been published as either a separate booklet or, more often, as a supplement to a scientific journal. The intention of these publications is to discuss the various aspects of UTI on a broad international base, to achieve a widely accepted consensus concerning management and clinical studies and to come to a growing bibliography on this subject, which could be useful for daily clinical decisions.
The following symposia have been published in the International Journal of Antimicrobial Agents and are freely available HERE
Volume 38, Supplement 1, pages 1-70 (December 2011)
Volume 31, Supplement 1, pages 1-116 (February 2008)
Volume 28, Supplement 1, pages 1-112 (August 2006)
Volume 24, Supplement 1, pages 1-75 (September 2004)
Volume 23, Supplement 1, pages 1-87 (March 2004)
Volume 22, Supplement 2, pages 27-100 (October 2003)
Future / Ongoing Activities
• All members included in several national and international guidelines in management of different types of UTI: American guidelines, European guidelines, Asian guidelines. One aim is to homogenize the guidelines and focus on the differences and common aspects of the guidelines.
• We do have studies such as registry studies, that are performed in different aspects of UTI (such as the GPIU study, etc.). We want to extend these studies further.
• We would like to extend our network of researchers engaged in urogenital infections, to serve as a platform where interventional studies can be faster performed, also as a network that can be contacted by pharmaceutical companies